Drug cancer cell treatment, Doxil, manufactured by Ayana Pharma, was launched a week ago, to the International Space Station, as part of the mission of SpaceX. The launch of the drug was made possible by SpacePharma, an Israeli start-up laboratory.
Certainly a cosmic breakthrough in the field of Space, this latest development could impact the treatment of drugs against cancer.
Doxil Nanotechnology Drug
A week ago, the pioneering study was launched without any intended witticism. The Falcon 9 launcher of SpaceX carried an extremely sophisticated laboratory that SpacePharma developed.
Their space laboratory is shrunk or mini version of the technology utilized for regular testing, although it weighs only four kilograms. It allows for more remote-controlled, actual-time testing to be carried out in space.
The objective of the study was to test if the cancer treatment, a nanotechnology drug that Ayana Pharma developed to treat cancer, would change in zero-gravity conditions. The study authors wanted to find out the drug itself or its actions against cancer cells would change the celestial space.
Essentially, Doxil is a complex-structure liposome drug formulated to treat ovarian cancer, several myelomas, or bone marrow cancer, as well as other contraindications.
The complex and unique structure of the drug makes it possible to test whether conditions of non-gravity, as they exist in space, affect the physical properties of the drug and its activity against cancer cells.
Probable Changes in the Nanoparticle Drug Investigated
Since the chemical and physical properties of Doxil and the cancer cell may differ under gravitational circumstances, the study authors will seek to investigate if there are changes in the nanoparticle, acceptance into cancer cells, the active substance that combats cancer cells, as well as its rate of discharge, and the drug’s distinctive envelope properties.
The notion behind this study is certainly to understand better the aspects of the drug, as it may specify a future probability of the efficacy in conditions of non-gravity.
The development of Doxil, detailed in the Chemocare site, was led by the Hebrew University’s Professor Yehezel Bernholtz, who, in 2012, founded Ayana Pharma.
The professor is recognized as a global expert in nanotechnology therapeutics, as Doxil was the first nanotechnology drug of the world approved by the Food and Drug Administration, as reported in the Fierce Pharma site.
His pharmaceutical firm focuses on both the development and production of liposomal drugs for cancer treatment, not just for cancer but also for other diseases.
News
New Drug Kills Cancer 20,000x More Effectively With No Detectable Side Effects
By restructuring a common chemotherapy drug, scientists increased its potency by 20,000 times. In a significant step forward for cancer therapy, researchers at Northwestern University have redesigned the molecular structure of a well-known chemotherapy drug, greatly [...]
Lipid nanoparticles discovered that can deliver mRNA directly into heart muscle cells
Cardiovascular disease continues to be the leading cause of death worldwide. But advances in heart-failure therapeutics have stalled, largely due to the difficulty of delivering treatments at the cellular level. Now, a UC Berkeley-led [...]
The basic mechanisms of visual attention emerged over 500 million years ago, study suggests
The brain does not need its sophisticated cortex to interpret the visual world. A new study published in PLOS Biology demonstrates that a much older structure, the superior colliculus, contains the necessary circuitry to perform the [...]
AI Is Overheating. This New Technology Could Be the Fix
Engineers have developed a passive evaporative cooling membrane that dramatically improves heat removal for electronics and data centers Engineers at the University of California San Diego have created an innovative cooling system designed to greatly enhance [...]
New nanomedicine wipes out leukemia in animal study
In a promising advance for cancer treatment, Northwestern University scientists have re-engineered the molecular structure of a common chemotherapy drug, making it dramatically more soluble and effective and less toxic. In the new study, [...]
Mystery Solved: Scientists Find Cause for Unexplained, Deadly Diseases
A study reveals that a protein called RPA is essential for maintaining chromosome stability by stimulating telomerase. New findings from the University of Wisconsin-Madison suggest that problems with a key protein that helps preserve chromosome stability [...]
Nanotech Blocks Infection and Speed Up Chronic Wound Recovery
A new nanotech-based formulation using quercetin and omega-3 fatty acids shows promise in halting bacterial biofilms and boosting skin cell repair. Scientists have developed a nanotechnology-based treatment to fight bacterial biofilms in wound infections. The [...]
Researchers propose five key questions for effective adoption of AI in clinical practice
While Artificial Intelligence (AI) can be a powerful tool that physicians can use to help diagnose their patients and has great potential to improve accuracy, efficiency and patient safety, it has its drawbacks. It [...]
Advancements and clinical translation of intelligent nanodrugs for breast cancer treatment
A comprehensive review in "Biofunct. Mater." meticulously details the most recent advancements and clinical translation of intelligent nanodrugs for breast cancer treatment. This paper presents an exhaustive overview of subtype-specific nanostrategies, the clinical benefits [...]
It’s Not “All in Your Head”: Scientists Develop Revolutionary Blood Test for Chronic Fatigue Syndrome
A 96% accurate blood test for ME/CFS could transform diagnosis and pave the way for future long COVID detection. Researchers from the University of East Anglia and Oxford Biodynamics have created a highly accurate [...]
How Far Can the Body Go? Scientists Find the Ultimate Limit of Human Endurance
Even the most elite endurance athletes can’t outrun biology. A new study finds that humans hit a metabolic ceiling at about 2.5 times their resting energy burn. When ultra-runners take on races that last [...]
World’s Rivers “Overdosing” on Human Antibiotics, Study Finds
Researchers estimate that approximately 8,500 tons of antibiotics enter river systems each year after passing through the human body and wastewater treatment processes. Rivers spanning millions of kilometers across the globe are contaminated with [...]
Yale Scientists Solve a Century-Old Brain Wave Mystery
Yale scientists traced gamma brain waves to thalamus-cortex interactions. The discovery could reveal how brain rhythms shape perception and disease. For more than a century, scientists have observed rhythmic waves of synchronized neuronal activity [...]
Can introducing peanuts early prevent allergies? Real-world data confirms it helps
New evidence from a large U.S. primary care network shows that early peanut introduction, endorsed in 2015 and 2017 guidelines, was followed by a marked decline in clinician-diagnosed peanut and overall food allergies among [...]
Nanoparticle blueprints reveal path to smarter medicines
Lipid nanoparticles (LNPs) are the delivery vehicles of modern medicine, carrying cancer drugs, gene therapies and vaccines into cells. Until recently, many scientists assumed that all LNPs followed more or less the same blueprint, [...]
How nanomedicine and AI are teaming up to tackle neurodegenerative diseases
When I first realized the scale of the challenge posed by neurodegenerative diseases, such as Alzheimer's, Parkinson's disease and amyotrophic lateral sclerosis (ALS), I felt simultaneously humbled and motivated. These disorders are not caused [...]
